<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="245">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 08, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00206895</url>
  </required_header>
  <id_info>
    <org_study_id>KF-01-177/04</org_study_id>
    <nct_id>NCT00206895</nct_id>
  </id_info>
  <brief_title>Photodynamic Therapy of Acne Vulgaris - a Randomized Blinded Controlled Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <authority>Denmark: Ministry of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluated the efficacy and tolerability of methyl
      aminolevulinate and 5-aminolevulinic acid photodynamic therapy in patients with moderate to
      severe facial acne vulgaris in a randomized controlled and investigator blinded trial.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2004</start_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Lesion counts (non-inflammatory and inflammatory)</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Leeds Revised Acne Grading System</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
  </secondary_outcome>
  <enrollment>24</enrollment>
  <condition>Acne Vulgaris</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Photodynamic therapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:18 years or older, good health, more than 12 inflammatory facial acne
        lesions -

        Exclusion Criteria:skin type VI, pregnant or lactating woman. Oral retinoid use within one
        year, systemic antibiotics within 1 month, topical acne treatment within 2 weeks.

        -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Hans Christian Wulf, MD, Sci</last_name>
    <role>Study Director</role>
    <affiliation>Bispebjerg Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Copenhagen NV</state>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2004</verification_date>
  <lastchanged_date>October 10, 2006</lastchanged_date>
  <firstreceived_date>September 12, 2005</firstreceived_date>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
